中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(7): 1626-1628

Chronic cholangitis with interstitial mucinous degeneration misdiagnosed as cholangiocarcinoma: A case report

DOI: 10.3969/j.issn.1001-5256.2022.07.031
  • a.

    Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, Shandong 256600, China

  • b.

    Department of Nursing, Binzhou Medical University Hospital, Binzhou, Shandong 256600, China

  • c.

    Clinical Nutrition Support Center, Binzhou Medical University Hospital, Binzhou, Shandong 256600, China

Research funding:

Nature Science Foundation of Shandong Province (ZR2015HL084)

More Information
  • Corresponding author: ZHANG Xingyuan, byfyzxy@163.com(ORCID: 0000-0002-7405-3805)
  • Received Date: 2021-09-02
  • Accepted Date: 2021-10-25
  • Published Date: 2022-07-20
    Abstract
    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    RIZVI S, KHAN SA, HALLEMEIER CL, et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018, 15(2): 95-111. DOI: 10.1038/nrclinonc.2017.157.
    [2]
    GAO B, ZHAO HY. Progress in the epidemiological characteristics and risk factors of intrahepatic cholangiocarcinoma[J]. J Mod Oncol, 2020, 28(7): 1214-1217. DOI: 10.3969/j.issn.1672-4992.2020.07.037.

    高博, 赵海鹰. 肝内胆管癌的流行病学特征及危险因素研究进展[J]. 现代肿瘤医学, 2020, 28(7): 1214-1217. DOI: 10.3969/j.issn.1672-4992.2020.07.037.
    [3]
    KHAN SA, TAVOLARI S, BRANDI G. Cholangiocarcinoma: Epidemiology and risk factors[J]. Liver Int, 2019, 39(Suppl 1): 19-31. DOI: 10.1111/liv.14095.
    [4]
    SCHIZAS D, MASTORAKI A, ROUTSI E, et al. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(6): 515-523. DOI: 10.1016/j.hbpd.2020.07.004.
    [5]
    PU T, FANG Q, CHEN ZX, et al. Advances in molecular pathogenesis and treatment of intrahepatic cholangiocarcinoma[J]. Chin J Dig Surg, 2020, 19(6): 697-702. DOI: 10.3760/cma.j.cn115610-20200504-00325.

    濮天, 方强, 陈子祥, 等. 肝内胆管癌发病机制及治疗相关进展[J]. 中华消化外科杂志, 2020, 19(6): 697-702. DOI: 10.3760/cma.j.cn115610-20200504-00325.
    [6]
    SHEN H, XIA Y, CHEN YB, et al. Risk factors analysis of intrahepatic cholangiocarcinoma after hepatectomy for hepatolithiasis[J]. Chin J Dig Surg, 2020, 19(8): 835-842. DOI: 10.3760/cma.j.cn115610-20200531-00402.

    沈皓, 夏勇, 陈玉宝, 等. 肝内胆管结石肝切除术后发生肝内胆管癌的危险因素分析[J]. 中华消化外科杂志, 2020, 19(8): 835-842. DOI: 10.3760/cma.j.cn115610-20200531-00402.
    [7]
    LI L, LIU H, SONG WY. Analysis of the clinical characteristics and diagnosis and treatment process of IgG4-related sclerosing cholangitis[J]. J Clin Hepatol, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.

    李丽, 刘晖, 宋文艳. IgG4相关硬化性胆管炎临床特征及诊疗过程分析[J]. 临床肝胆病杂志, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.
    [8]
    RIZVI S, GORES GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma[J]. Gastroenterology, 2013, 145(6): 1215-1229. DOI: 10.1053/j.gastro.2013.10.013.
    [9]
    DOHERTY B, NAMBUDIRI VE, PALMER WC. Update on the diagnosis and treatment of cholangiocarcinoma[J]. Curr Gastroenterol Rep, 2017, 19(1): 2. DOI: 10.1007/s11894-017-0542-4.
    [10]
    MA WJ, SHRESTHA A, LI FY. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value?[J]. Cancer Med, 2016, 5(10): 2848-2849. DOI: 10.1002/cam4.920.
    [11]
    MACIAS R, KORNEK M, RODRIGUES PM, et al. Diagnostic and prognostic biomarkers in cholangiocarcinoma[J]. Liver Int, 2019, 39(Suppl 1): 108-122. DOI: 10.1111/liv.14090.
    [12]
    WANG TL, WU G. Progress in diagnosis and treatment of IgG4 associated sclerosing cholangitis[J]. Chin J Gerontol, 2021, 41(14): 3145-3148. DOI: 10.3969/j.issn.1005-9202.2021.14.063.

    王天龙, 吴刚. IgG4相关硬化性胆管炎的诊治进展[J]. 中国老年学杂志, 2021, 41(14): 3145-3148. DOI: 10.3969/j.issn.1005-9202.2021.14.063.
    [13]
    XIAO J, LI G, YANG G, et al. Case report: A female case of isolated IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma[J]. Medicine(Baltimore), 2017, 96(16): e6542. DOI: 10.1097/MD.0000000000006542.
    [14]
    TANAKA A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis[J]. Gut Liver, 2019, 13(3): 300-307. DOI: 10.5009/gnl18085.
    [15]
    LLEO A, MARZORATI S, ANAYA JM, et al. Primary biliary cholangitis: a comprehensive overview[J]. Hepatol Int, 2017, 11(6): 485-499. DOI: 10.1007/s12072-017-9830-1.
    [16]
    NGUYEN CANH H, HARADA K. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma[J]. Med Mol Morphol, 2016, 49(4): 189-202. DOI: 10.1007/s00795-016-0143-6.
    [17]
    MA MX, JAYASEKERAN V, CHONG AK. Benign biliary strictures: Prevalence, impact, and management strategies[J]. Clin Exp Gastroenterol, 2019, 12: 83-92. DOI: 10.2147/CEG.S165016.
    [18]
    LIANG BY, HUANG ZY, ZHANG ZY, et al. Etiology, diagnosis and treatment of benign hepatic portal biliary stenosis[J]. J Abdom Surg, 2016, 29(5): 327-330. DOI: 10.3969/j.issn.1003-5591.2016.05.003.

    梁宾勇, 黄志勇, 张尊义, 等. 肝门部胆管良性狭窄的病因、诊断及治疗[J]. 腹部外科, 2016, 29(5): 327-330. DOI: 10.3969/j.issn.1003-5591.2016.05.003.
    [19]
    TANG ZW, MENG WB, LI X. Status and controversy of preoperative diagnosis and bile duct cholangiocarcinoma drainage strategy[J]. J Lanzhou Univ, 2019, 45(2): 67-74. DOI: 10.13885/j.issn.1000-2812.2019.02.012.

    唐增伟, 孟文勃, 李汛. 肝门部胆管癌术前诊断及胆道引流策略的现状与争议[J]. 兰州大学学报, 2019, 45(2): 67-74. DOI: 10.13885/j.issn.1000-2812.2019.02.012.
    [20]
    XU W, MIAO L, WANG ZF, et, al. Application of SpyGlass TM DS in diagnosis and treatment of biliary diseases[J]. J Clin Hepatol, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.

    徐雯, 苗龙, 王正峰, 等. SpyGlass TM DS直视化系统在胆道疾病诊疗中的应用[J]. 临床肝胆病杂志, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.
    [21]
    ZHANG GJ, ZHANG DY, CAI FC, et al. New development of endoscopic retrograde cholangiopancreatography in the diagnosis and treatment[J/CD]. Chin J Gastrointestinal Endosc(Electronic Edition), 2020, 7(4): 205-210. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.008.

    张贯军, 张大涯, 蔡逢春, 等. 内镜逆行胰胆管造影术诊治新进展[J/CD]. 中华胃肠内镜电子杂志, 2020, 7(4): 205-210. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.008.
    [22]
    TAGHAVI SA, ESHRAGHIAN A, NIKNAM R, et al. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(6): 575-584. DOI: 10.1080/17474124.2018.1473761.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (763) PDF downloads(29) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return